Correction: VTX-PID as a novel recombinant immunoglobulin G–degrading enzyme (IdeS) for efficient AAV-based gene therapy in participants with neutralizing antibodies: results of the phase I first-in-human NAVIgATE study - Top-Institutions - MDSpire

Correction: VTX-PID as a novel recombinant immunoglobulin G–degrading enzyme (IdeS) for efficient AAV-based gene therapy in participants with neutralizing antibodies: results of the phase I first-in-human NAVIgATE study

  • By

  • Bernard Benichou

  • Rainard Fuhr

  • Elodie Vernadal

  • Sonia Valero

  • Blanche Tamarit

  • Veronica Ferrer

  • Gloria Gonzalez-Aseguinolaza

  • Anne Douar

  • Marc Froissart

  • Annelise Brossel

  • Simone Floettmann

  • Francesca Del Bene

  • Céline Bouquet

  • Jean-Philippe Combal

  • June 17, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    University of Pennsylvania/Children’s Hospital of Philadelphia
    University of Pennsylvania/Children’s Hospital of Philadelphia

    Philadelphia, Pennsylvania

    Key Differentiators

    • Gene Therapy
    • Immunology

  • #2

    Nationwide Children’s Hospital/Abigail Wexner Research Institute
    Nationwide Children’s Hospital/Abigail Wexner Research Institute

    Columbus, Ohio

    Key Differentiators

    • Gene Therapy
    • Pediatric Immunology

Original Source(s)

Correction: VTX-PID as a novel recombinant immunoglobulin G–degrading enzyme (IdeS) for efficient AAV-based gene therapy in participants with neutralizing antibodies: results of the phase I first-in-human NAVIgATE study

  • by Bernard Benichou, Rainard Fuhr, Elodie Vernadal, Sonia Valero, Blanche Tamarit, Veronica Ferrer, Gloria Gonzalez-Aseguinolaza, Anne Douar, Marc Froissart, Annelise Brossel, Simone Floettmann, Francesca Del Bene, Céline Bouquet, Jean-Philippe Combal

  • June 17, 2026

Related Content

TLR7/8 agonist 3M-052 formulated in micelles induces local type I IFN response and antiviral immunity in zebrafish larvae

Does Sedative Choice Shape Later Cognition?

Researchers examined long-term cognitive outcomes among children who received ICU sedation for acute respiratory failure.

Invasive tracheal mucormycosis causing irreversible glottic closure and long-term tracheostomy dependence: a case report and airway-centered management implications